Tumor Necrosis Factor Receptors 6alpha and 6beta

Details for Australian Patent Application No. 2003259621 (hide)

Owner Human Genome Sciences, Inc.

Inventors Ni, Jian; Ruben, Steven M; Ebner, Reinhard; Gentz, Reiner L; Feng, Ping; Yu, Guo-Liang

Agent Wrays

Pub. Number AU-A-2003259621

Parent 763955

Filing date 3 November 2003

Wipo publication date 27 November 2003

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

13 November 2003 Complete Application Filed

27 November 2003 Application Open to Public Inspection

  Published as AU-A-2003259621

30 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003259622-Gene expressed in prostate cancer

2003259620-An Improved Plaque Discloser